A survey of monitoring of weight and blood glucose in in-patients
Open Access
- 1 November 2003
- journal article
- Published by Royal College of Psychiatrists in Psychiatric Bulletin
- Vol. 27 (11) , 424-426
- https://doi.org/10.1192/pb.27.11.424
Abstract
AIMS AND METHOD The aim of this survey was to look at current practice in monitoring weight and glucose control in in-patients being prescribed antipsychotic medications. Records for 51 patients admitted with psychotic illnesses to a large teaching hospital during a 3-month interval were surveyed. RESULTS Fifty-five per cent of patients had no record of weight taken on admission to hospital. Only one patient had their weight repeated during the admission. Forty-nine per cent of patients had random blood glucose checked on admission. No fasting levels were performed. CLINICAL IMPLICATIONS Weight gain and hyperglycaemia associated with antipsychotic prescription are well-recognised side-effects. These results suggest that standardisation of weight measurement and blood glucose monitoring is required.Keywords
This publication has 5 references indexed in Scilit:
- Atypical antipsychotics and hyperglycaemiaInternational Clinical Psychopharmacology, 2001
- Bodyweight Gain with Atypical AntipsychoticsDrug Safety, 2001
- Causes of the excess mortality of schizophreniaThe British Journal of Psychiatry, 2000
- Antipsychotic-Induced Weight Gain: A Comprehensive Research SynthesisAmerican Journal of Psychiatry, 1999
- Body weight gain induced by antipsychotic drugs: mechanisms and managementActa Psychiatrica Scandinavica, 1999